Company Overview and News
Sysco Corporation (SYY - Free Report) has been in investors’ good books for quite some time now, courtesy of its splendid past record. The company has been gaining from a host of factors, especially its key growth strategies and strong U.S. Foodservice unit. This is well-reflected in its performance, as Sysco rallied as much as 41.3% in a year, against the industry’s decline of 2.5%.
LW SYY MED SAM BGS
General Mills, Inc. (GIS - Free Report) , which remains focused on the Consumer First strategy, provided details on its global growth priorities at its annual Investor Day. Talking of Consumer First strategy, management believes that meeting consumers’ evolving needs is one of the vital strategies for its business. This also helped the company to return to top-line growth in fiscal 2018. That said, let’s delve deeper into the company’s global growth priorities, which should most likely help it sustain top-line growth and uplift investors’ confidence in this Zacks Rank #3 (Hold) stock.
LMT BUFF GIS MED ADI BGS CHEF
Helen of Troy Limited (HELE - Free Report) surprised investors with a spectacular start to fiscal 2019. Notably, both top and bottom lines grew year over year and topped estimates in the first quarter of fiscal 2019. While sales marked its second straight beat, earnings kept its positive surprise streak alive for the twelfth consecutive quarter. Moreover, management raised its bottom-line view and Project Refuel target, which was clearly a treat for investors.
HELE MED BGS CHEF
It hasn’t even been two weeks since McCormick & Company, Incorporated (MKC - Free Report) released second-quarter fiscal 2018 results, wherein its shares have gained 13.2%. In fact, the company has been in investors’ good books for quite some time now. Evidently, this Zacks Rank #3 (Hold) stock has rallied 18.6% in the past six months, against the industry’s decline of 3.7%. Let’s take a sneak peek into McCormick’s second-quarter performance and see if McCormick’s growth driver can help it sustain its solid record amid cost hurdles.
MED CVRR BGS CHEF
Risks and uncertainties in the financial markets suggest that portfolios with heavy interest rate risk might consider more diversification.
CLNS CLNS.PRJ CLNS.PRI CLNS.PRH CLNS.PRG CLNS.PRE HOG CLNS.PRD GME CLNS.PRB USA CLNS.PRDCL PII BGS
General Mills, Inc. (GIS - Free Report) shares have lost 26.2% in the past six months, wider than the industry’s decline of 7.7%. This can be blamed on input cost inflation, which remains a threat to the company’s margins and is a major hurdle for the overall food space. Markedly, the Zacks Food-Miscellaneous industry is placed among the bottom 16% out of more than 250 Zacks industries.
GIS DB MED BGS CHEF DLPH
Service Corporation International (SCI - Free Report) has seen its shares rally 11.4% over the past year, outpacing the industry’s growth of 9.7%. It is the largest deathcare products and services provider in North America, which has been riding on its strategic growth efforts as well as strong funeral service revenues. Let’s delve deeper and see if these factors can help Service Corporation sustain growth amid soft cemetery preneed sales.
BHI BLT BHP BHPBF MED BBL BHP SCI BHPLF BGS CHEF
Dean Foods Company (DF - Free Report) remains committed toward strengthening its brands portfolio to make the most of consumers’ rising inclination toward healthy and nutritional products. To this end, the company raised its ownership stake in Good Karma Foods, in which it had made a minority investment in May 2017. Dean Foods’ majority stake in Good Karma reflects its solid brand building strategy.
ABX MED BGS CHEF ABX
In a bid to expand the auto appearance portfolio, Energizer Holdings, Inc (ENR - Free Report) , also known as Energizer, has signed an agreement with Reed-Union Corporation (Reed-Union). Energizer will acquire Reed-Union’s automotive appearance business, which includes the Nu Finish Car Polish and Nu Finish Scratch Doctor brands.
SPB ARW MED ENR BGS
General Mills, Inc. (GIS - Free Report) delivered fourth-quarter fiscal 2018 results, wherein both top and bottom lines grew year over year and the latter beat the Zacks Consensus Estimate, after two successive quarters of in-line results. Shares of the company are up 2.5% during the pre-market trading hours. Further, this Zacks Rank #3 (Hold) company has gained 8% in a month, outpacing the industry’s 6% rise.
GIS MED BGS CHEF
The Hain Celestial Group, Inc. (HAIN - Free Report) recently announced plans to appoint a new chief executive officer. Meanwhile, Irwin D. Simon, the present founder, president and chief executive officer, will serve as non-executive chairman of the board.
MED HAIN BGS CHEF
B&G Foods, Inc. (BGS - Free Report) appears to be a solid bet. Shares of the company have risen 30.7% in the past three months, outperforming the industry’s growth of 4%.
ACAS EPC TATYY KMI.WS SM KMI.PRA KMI AMBKP MED ZAGG KMR KMRFZ CVB BGS
Shares of Archer Daniels Midland Company (ADM - Free Report) have reached a 52-week high of $46.41 on Jun 20, though it closed a tad lower at $46.17. Year to date, the stock has gained 16.9%, outperforming the industry’s 8% rise. This upside can be primarily attributed to the company’s robust growth strategies, including progress on its portfolio management initiatives, cost-savings plan and Readiness program.
CLXT MS.PRI MS.PRK MED MS.PRE MS.PRF MS.PRG MS ADM MS.PRA BGS PDCO
Helen of Troy Limited’s (HELE - Free Report) stock has been moving up the charts, thanks to its focus on strategic growth initiatives, which have also helped the company put up an impressive record. Well, this consumer products player has gained 14.3% in the past three months, outpacing the industry’s 1.6% growth. So, let’s take a closer view of the factors that have spurred investors’ confidence in this Zacks Rank #2 (Buy) stock, which is most likely to keep its spectacular show on.
IPAR HELE BGS CHEF
2018-07-13 - Asif
Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...
2018-07-09 - Asif
Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...
2018-07-06 - Asif
Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...
Silicon Investor Message Boards
This table lists all message boards related to BGS / B&G Foods, Inc. on message board site Silicon Investor.
|BGST: BigStar Entertainment|
as of ET